TNF alpha gene-silencing siRNAs (Geneaty therapeutics/KAIMRC)

N/A

Report date: 2025/03/20 10:00:32
NME

Base Information

Drug NameTNF alpha gene-silencing siRNAs (Geneaty therapeutics/KAIMRC)
Drug Alias NameGT-TNF alpha-SLN 2.0 001KAIMRC-GT5-TNF-alpha siRNA-SLNsRNAi therapeutics (Geneaty therapeutics/KAIMRC)
ClassificationSmall molecules > LipidSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsInflammationArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSaudi Arabia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKing Abdullah International Medical Research Center
China Registration ClassN/A

Develop Information

Active CompaniesGeneaty Therapeutics IncKing Abdullah International Medical Research Center
Inactive CompaniesN/A
Active IndicationsInflammationArthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A